Live feed08:00:00·2031dPRReleasevia QuantisnowMinerva Neurosciences Announces Outcome of Type C Meeting with FDA and Next Steps in the Development of RoluperidoneByQuantisnow·Wall Street's wire, on your screen.NERV· Minerva Neurosciences IncHealth CareOriginal source
